Posts tagged as:

naproxen sodium

Treximet (formerly Trexima)

by James on 15 May 2008

The drug now known as Treximet has been approved for sale in the USA (on the 15th of April, 2008).  It’s expected to hit the shelved any time now, as a prescription medicine.
But what is Treximet (formerly Trexima)?  And is it worth all the hype?
Actually, I’ve written about Treximet several times before (here for example) [...]

{ 41 comments }

Trexima (and the problem with a double-drug)

by James on 16 April 2007

You might have heard about Pozen’s migraine product, Trexima, which is currently under review in the USA.  I know I’ve heard about it – a lot about it.  I’ve written about Trexima before, more than once.
Trexima is a combination drug.  Its key ingredients are sumatriptan succinate (otherwise known as Imitrex) and naproxen sodium.  Both of [...]

{ 0 comments }

MT 100 coming to the UK

by James on 1 December 2005

MT 100, an oral migraine drug from Pozen, was been approved in the UK on Monday (28 Nov).  The drug contains naproxen sodium and metoclopramide.  Naproxen sodium is familiar to migraineurs, it reduces pain and inflammation, and is often used for migraine brought on by hormonal changes.  Metoclopramide has been used to reduce pain and [...]

{ 0 comments }

One new drug set aside, another on the way…

by James on 6 August 2005

Pozen, Inc. has decided to stop developing its new migraine drug, MT 100.  The Naproxen Sodium and Metoclopramide Hydrochloride drug needed more trials, the FDA concluded.  There have been concerns that it may cause tardive dyskinesia, a chronic disorder of the nervous system causing jerky movements in the face, tongue, and other parts of the [...]

{ 1 comment }